Metraipolis › archive › dc_a7c41fb6d033
Generative Artificial Intelligence Transitions Pharmaceutical Development from Empirical Screening to Predictive Molecular Design and Clinical Trial… — Europe PMC PMID:42075869
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42075869
- DOI
- 10.3390/ph19040614
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T00:32:21.692Z
- SHA-256 of the archived text
4bbba1800d22ddd920a4d5d9f8751a5a3c07dcf16d96c93162d82fe466fbeab0- Stable URL of this page
https://metraipolis.com/documento/dc_a7c41fb6d033
How to cite
Generative Artificial Intelligence Transitions Pharmaceutical Development from Empirical Screening to Predictive Molecular Design and Clinical Trial… — Europe PMC PMID:42075869 — Europe PMC (en), https://europepmc.org/article/MED/42075869 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7c41fb6d033 (Metraipolis archive dc_a7c41fb6d033, sha256 4bbba1800d22ddd920a4d5d9f8751a5a3c07dcf16d96c93162d82fe466fbeab0)
BibTeX
@misc{dca7c41fb6d033,
title = {Generative Artificial Intelligence Transitions Pharmaceutical Development from Empirical Screening to Predictive Molecular Design and Clinical Trial… — Europe PMC PMID:42075869},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42075869},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7c41fb6d033; sha256 4bbba1800d22ddd920a4d5d9f8751a5a3c07dcf16d96c93162d82fe466fbeab0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42075869. Agents can read the archived copy with the MCP tool read_document.